Corticosteroid preparations (topical) - Clinical trials 

  • Clinical trials

Clinical trials for Corticosteroid preparations (topical)

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Corticosteroid preparations (topical). For all clinical trials, go to clinical trials search

This list shows clinical trials for Corticosteroid preparations (topical)

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Corticosteroid preparations (topical)
Title Recruitment status Location
Is potent topical corticosteroid ointment covered by a plastic film dressing more effective than using potent corticosteroid ointment alone in children with atopic dermatitis? Authorised United Kingdom
Fluocinonide Cream in Treating Symptoms of Vaginal Dryness and Painful Sexual Intercourse In Patients With Breast Cancer Undergoing Hormone Therapy Recruiting United States
Corticosteroid eye-drops for bacterial keratitis Recruiting New Zealand
A Randomized Clinical Trial of the Effect of Pimecrolimus Cream 1% Compared With Topical Corticosteroid in Treatment of Erosive Oral Lichen Planus Not recruiting Iran, Islamic Republic of
NdYag Laser for Acne Keloidalis Nuchae Not recruiting United States
Comparison of therapeutic efficacy of topical corticosteroid and oral zinc sulfate-topical corticosteroid combination in the treatment of vitiligo patients: a randomized clinical trial Not Recruiting Iran
A 16-week, randomized, multi-center, parallel-group, pimecrolimus-blinded, controlled study (4-week treatment period followed by 12-week observational period) to evaluate the safety of concomitant use of ASM 981 (pimecrolimus) cream 1% (BID) plus topical corticosteroid (BID) for the treatment of severe atopic dermatitis in patients 2 to 17 years of age. Not Recruiting Germany
A 16-week, randomized, multi-center, parallel-group, pimecrolimus-blinded, controlled study (4-week treatment period followed by 12-week observational period) to evaluate the safety of concomitant use of ASM 981 (pimecrolimus) cream 1% (BID) plus topical corticosteroid (BID) for the treatment of severe atopic dermatitis in patients 2 to 17 years of age. Not Recruiting Italy
A single-center, randomized, controlled, observer-blind, phase IV study to develop the atopic localized eczema regression test (ALERT) using marketed topical corticosteroid formulations of different strength and the calcineurin inhibitors pimecrolimus (Elidel®) in patients with a pre-disposition for atopic dermatitis - Atopic localized eczema regression test (ALERT) Not Recruiting Germany
Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic Dermatitis Not recruiting United States
  • Link to Directgov – public services all in one place
  • The Information Standard - Certified member